Literature DB >> 29330473

Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy.

Ditmer T Talsma1, Kirankumar Katta2,3,4, Marieke A B Ettema1, Berna Kel1, Marion Kusche-Gullberg3, Moh R Daha1, Coen A Stegeman1, Jacob van den Born5, Lianchun Wang6.   

Abstract

Inflammation plays a vital role in the development of diabetic nephropathy, but the underlying regulatory mechanisms are only partially understood. Our previous studies demonstrated that, during acute inflammation, endothelial heparan sulfate (HS) contributes to the adhesion and transendothelial migration of leukocytes into perivascular tissues by direct interaction with L-selectin and the presentation of bound chemokines. In the current study, we aimed to assess the role of endothelial HS on chronic renal inflammation and fibrosis in a diabetic nephropathy mouse model. To reduce sulfation of HS specifically in the endothelium, we generated Ndst1 f/f Tie2Cre + mice in which N-deacetylase/N-sulfotransferase-1 (Ndst1), the gene that initiates HS sulfation modifications in HS biosynthesis, was expressly ablated in endothelium. To induce diabetes, age-matched male Ndst1 f/f Tie2Cre - (wild type) and Ndst1 f/f Tie2Cre + mice on a C57Bl/6J background were injected intraperitoneally with streptozotocin (STZ) (50 mg/kg) on five consecutive days (N = 10-11/group). Urine and plasma were collected. Four weeks after diabetes induction the animals were sacrificed and kidneys were analyzed by immunohistochemistry and qRT-PCR. Compared to healthy controls, diabetic Ndst1 f/f Tie2Cre - mice showed increased glomerular macrophage infiltration, mannose binding lectin complement deposition and glomerulosclerosis, whereas these pathological reactions were prevented significantly in the diabetic Ndst1 f/f Tie2Cre + animals (all three p < 0.01). In addition, the expression of the podocyte damage marker desmin was significantly higher in the Ndst1 f/f Tie2Cre - group compared to the Ndst1 f/f Tie2Cre + animals (p < 0.001), although both groups had comparable numbers of podocytes. In the cortical tubulo-interstitium, similar analyses show decreased interstitial macrophage accumulation in the diabetic Ndst1 f/f Tie2Cre + animals compared to the diabetic Ndst1 f/f Tie2Cre - mice (p < 0.05). Diabetic Ndst1 f/f Tie2Cre + animals also showed reduced interstitial fibrosis as evidenced by reduced density of αSMA-positive myofibroblasts (p < 0.01), diminished collagen III deposition (p < 0.001) and reduced mRNA expression of collagen I (p < 0.001) and fibronectin (p < 0.001). Our studies indicate a pivotal role of endothelial HS in the development of renal inflammation and fibrosis in diabetic nephropathy in mice. These results suggest that HS is a possible target for therapy in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29330473      PMCID: PMC6247417          DOI: 10.1038/s41374-017-0015-2

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  39 in total

Review 1.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

Review 2.  Targeting inflammation in diabetic kidney disease: early clinical trials.

Authors:  Maria Vanessa Perez-Gomez; Maria Dolores Sanchez-Niño; Ana Belen Sanz; Binbin Zheng; Catalina Martín-Cleary; Marta Ruiz-Ortega; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  Expert Opin Investig Drugs       Date:  2016-06-13       Impact factor: 6.206

Review 3.  Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier García-Pérez
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

4.  Temporal trends in the prevalence of diabetic kidney disease in the United States.

Authors:  Ian H de Boer; Tessa C Rue; Yoshio N Hall; Patrick J Heagerty; Noel S Weiss; Jonathan Himmelfarb
Journal:  JAMA       Date:  2011-06-22       Impact factor: 56.272

Review 5.  Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily.

Authors:  C C Rider
Journal:  Biochem Soc Trans       Date:  2006-06       Impact factor: 5.407

6.  Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy.

Authors:  Hwal Woong Kim; Bong Cho Kim; Chi Young Song; Ji Hoon Kim; Hye Kyoung Hong; Hyun Soon Lee
Journal:  Kidney Int       Date:  2004-11       Impact factor: 10.612

7.  Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

Authors:  F Y Chow; D J Nikolic-Paterson; F Y Ma; E Ozols; B J Rollins; G H Tesch
Journal:  Diabetologia       Date:  2006-12-12       Impact factor: 10.122

8.  Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.

Authors:  K Sharma; Y Jin; J Guo; F N Ziyadeh
Journal:  Diabetes       Date:  1996-04       Impact factor: 9.461

9.  Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion.

Authors:  Johanna W A M Celie; Niels W P Rutjes; Eelco D Keuning; Raija Soininen; Ritva Heljasvaara; Taina Pihlajaniemi; Angelika M Dräger; Sonja Zweegman; Floortje L Kessler; Robert H J Beelen; Sandrine Florquin; Jan Aten; Jacob van den Born
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

10.  Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement.

Authors:  Jan A J G van den Brand
Journal:  Clin Kidney J       Date:  2016-05-24
View more
  14 in total

1.  Heparan sulfate inhibits transforming growth factor β signaling and functions in cis and in trans to regulate prostate stem/progenitor cell activities.

Authors:  Sumit Rai; Omar Awad Alsaidan; Hua Yang; Houjian Cai; Lianchun Wang
Journal:  Glycobiology       Date:  2020-05-19       Impact factor: 4.313

Review 2.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

Review 3.  Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation.

Authors:  Ariane R Pessentheiner; G Michelle Ducasa; Philip L S M Gordts
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

Review 4.  Novel Insights Into the Role of Glycans in the Pathophysiology of Glomerular Endotheliosis in Preeclampsia.

Authors:  M F Galvis-Ramírez; J C Quintana-Castillo; J C Bueno-Sanchez
Journal:  Front Physiol       Date:  2018-10-23       Impact factor: 4.566

5.  Syndecans and Enzymes for Heparan Sulfate Biosynthesis and Modification Differentially Correlate With Presence of Inflammatory Infiltrate in Periodontitis.

Authors:  Roko Duplancic; Marija Roguljic; Ivan Puhar; Nika Vecek; Ruzica Dragun; Katarina Vukojevic; Mirna Saraga-Babic; Darko Kero
Journal:  Front Physiol       Date:  2019-09-25       Impact factor: 4.566

6.  ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway.

Authors:  Yu-Li Shen; Yi-Ping Jiang; Xiao-Qin Li; Su-Juan Wang; Ming-Hua Ma; Chun-Yan Zhang; Jian-Yong Zhu; Khalid Rahman; Li-Jun Zhang; Xin Luan; Hong Zhang
Journal:  Front Pharmacol       Date:  2020-01-24       Impact factor: 5.810

Review 7.  Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment.

Authors:  Claire E McQuitty; Roger Williams; Shilpa Chokshi; Luca Urbani
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

8.  Novel approach for quantification of multiple immunofluorescent signals using histograms and 2D plot profiling of whole-section panoramic images.

Authors:  Roko Duplancic; Darko Kero
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

9.  STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes.

Authors:  Darukeshwara Joladarashi; Yanan Zhu; Matthew Willman; Kevin Nash; Maria Cimini; Rajarajan Amirthalingam Thandavarayan; Keith A Youker; Xuehong Song; Di Ren; Ji Li; Raj Kishore; Prasanna Krishnamurthy; Lianchun Wang
Journal:  Front Cardiovasc Med       Date:  2022-01-13

Review 10.  Regulation of Monocytes/Macrophages by the Renin-Angiotensin System in Diabetic Nephropathy: State of the Art and Results of a Pilot Study.

Authors:  Claudine Moratal; Audrey Laurain; Mourad Naïmi; Thibault Florin; Vincent Esnault; Jaap G Neels; Nicolas Chevalier; Giulia Chinetti; Guillaume Favre
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.